Requirement of phenylephrine to treat fall in blood pressure after spinal anaesthesia in two different types of preeclampsia patients
Phase 4
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2024/05/066787
- Lead Sponsor
- niversity College of Medical Sciences and Guru Teg Bahadur Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Preeclamptic females with singleton pregnancy of 34 weeks gestation or more undergoing caesarean
section under spinal anaesthesia
Exclusion Criteria
1. Maternal complications other than preeclampsia such as chronic hypertension, other cardiovascular
disease, cerebrovascular disease
2. Multiple gestation
3. Eclampsia
4. Known fetal abnormality
5. Patients with absolute or relative contra-indications for spinal anaesthesia
6. Severe fetal distress or other conditions requiring immediate induction of general anaesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total phenylephrine requirementsTimepoint: From the time of administration of spinal anaesthesia to the time of delivery of baby
- Secondary Outcome Measures
Name Time Method 1. Maternal haemodynamic variables <br/ ><br>2. Total number of hypotensive episodes <br/ ><br>3. Incidence of reactive hypertension & bradycardia <br/ ><br>4. Neonatal Apgar scores & fetal acid-base status <br/ ><br>5. Maternal complications such as nausea, vomiting, dizziness or any other complicationsTimepoint: From the time of administration of spinal anaesthesia to the time of delivery of baby